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hat is the National Library of Medicine and What Does It Do?  
The National Library of Medicine (NLM) joined the National Institutes of 
Health (NIH) in 1968.  As an NIH Institute, NLM conducts and supports 
research and training in information science, informatics, and data science.  The NLM 
is also the world’s largest biomedical and medical library, tracing its origins to the li-
brary of the Office of the Surgeon General of the Army in 1836ii.  Today, in addition to 
its large collections of physical items, including books, journals, manuscripts, photo-
graphs, and other items, NLM is also home to hundreds of digital data and information 
resources.  These include major resources, such as ClinicalTrials.goviii, which houses 
information about and from hundreds of thousands of clinical trials, and Med-
linePlusiv, which provides authoritative consumer health information, as well as 
smaller resources serving important niche purposes, such as TOXNET, which is a col-
lection of databases and information products related to toxicology, environmental 
health, and hazardous substancesv.   
Every day, NLM receives more than 
10 terabytes of digital content from more 
than 3000 users, and delivers more than 
100 terabytes to more than 4 million us-
ers, often through application program-
ming interfaces. Users of these resources 
include researchers, healthcare provid-
ers, and the general public. The Library 
supports activities that engage all catego-
ries of users to make its resources known, 
understood and used. For example, to fa-
cilitate and enhance health information 
access to the general public throughout 
the country, including many rural areas, 
the NLM supports the National Network 
of Libraries of Medicinevi.  Through its 
eight regional medical libraries, the Net-
work reaches more than 6500 points of 
presence across the country in academic 
health science, community college, tribal 
college and public libraries, as well as 
other organizations, such as community 
health centers. 
With medicine and biomedicine as its 
substantive scope, the NLM has been 
paying attention to that literature for 
more than 180 years.  In 1879, John Shaw 
Billings, Director of the Library of the 
Surgeon General of the Army, and Robert 
Fletcher compiled and had published In-
dex Medicus, an index of medical books, 
journals, and pamphletsvii.  Stewarded by 
NLM, Index Medicus continued to be the 
authoritative index of the medical litera-
ture until 2004, but by 1964 the Library 
had started compiling citations and in-
dexing much of the biomedical and med-
ical literature digitally, in a database sys-
tem called MEDLARS.  In 1971, this data-
base became available online (mostly 
W 
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through university libraries) as MED-
LINEviii.  And, in 1997, PubMed, which 
included MEDLINE bibliographic data 
and more, was launched for free use by 
anyone on the World Wide Web. Today, 
PubMed contains more than 27 million 
bibliographic citationsix. 
In addition to bibliographic data, 
NLM has established databases and re-
sources for particular types of research 
data.  These include GenBank, a database 
containing all publicly available DNA se-
quence data with annotationsx, and oth-
ersxi.  As biomedical research becomes in-
creasingly digital, the NLM will likely 
pay attention to research objects beyond 
research data and bibliographic data. 
Such digital research objectsxii (DROs) 
might include software used to generate 
or analyze research data, as well as mod-
els, workflows, etc., used in research. (It 
is important to note that “pay attention 
to” covers a broad range of possible activ-
ities.)  To DROs, such as citations or da-
tasets, NLM applies:  information science 
to curate acquired objects, informatics to 
compute in context on these objects, and 
data science to extract insight from these 
objects. After this, the DROs are findable 
(e.g., by having had metadata assigned), 
accessible (e.g., through publicly accessi-
ble databases), interoperable (e.g., by 
having adopted common data-related 
standards), and re-usable (e.g., by linking 
one set of objects, like publication cita-
tions, to another set of objects, like the da-
tasets reported on in those publications). 
Thus, the processes of NLM applied to 
DROs make those objects compliant with 
the FAIR Principlesxiii.  In addition, NLM 
is interested in making DROs attributable 
(e.g., through PubMed Identifiers, 
PMIDs, or GenBank Accession Numbers) 
and sustainable (NLM considers this 
carefully before committing to hosting 
DROs).    
The Importance of Being FAIR 
When DROs are findable, accessible, 
interoperable, re-usable, and attributable, 
they make possible a more data-centric 
and open paradigm of science and schol-
arship, where the products and processes 
of research can populate an ecosystem 
that allows for others than those who pro-
duced specific DROs to add value to the 
science and scholarship around them. 
The starting point for bringing DROs into 
this more open ecosystem is to share 
DROs, especially data.  Benefits of shar-
ing data and other DROs can include 
(depending how interoperable they are 
with other data and tools):  providing a 
deeper understanding of the publica-
tions and ideas with which they are as-
sociated, gaining additional insight by 
reanalysis of the data, boosting statisti-
cal power to answer particular ques-
tions by aggregating multiple datasets, 
ability to apply big data analytic meth-
ods, broadening opportunities for col-
laboration, enhancing accountability 
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(e.g., assessing reproducibility) and in-
creasing return on research investments 
for research participants, science, and so-
ciety.   
Of course, there are also objections to 
such sharing, including:  the costs in-
curred by making data and other DROs 
FAIR and sharing them, the possibility of 
others using the shared data to publish 
before the lab that produced the data 
does, concerns about intellectual prop-
erty, patient privacy, and confidentiality, 
the fact that credit is accrued to investiga-
tors for papers published but not for 
data-related activities (so efforts not di-
rected at publishing represent a net loss), 
the concern that data will not be under-
stood and that the data will be misused. 
Most of these objections can be, and in 
some cases have already been, overcome 
(e.g., support of funders for data-sharing 
activities, use of embargo periods so shar-
ing data happens after publication, and a 
host of policy and practice solutions to 
address intellectual property and patient 
privacy concerns).  Yet, some, such as the 
lack of incentives for data-sharing, will 
require broad changes in the enterprise, 
while others still, such as the misuse of 
data, may never be fully resolved. 
Conducting biomedical research in a 
more data-centric and open paradigm 
has repeatedly been shown to add signif-
icant value to science and scholarship. 
This was perhaps most famously demon-
strated by the Human Genome Project, a 
13-year project launched in 1990 that fun-
damentally changed the direction of bio-
medical research, and transformed our
understanding of health and illness
xviii
xiv.
The spectacular success of the Human
Genome Project was powered by collabo-
rations and interactions of investigators
in the ecosystem wrought of its findable, 
accessible, interoperable, re-usable data, 
tools, and infrastructure.  Since then, 
many large-scale data-centric and open 
research initiatives have proven the value 
of these paradigms, including the Human 
Connectome Project and its subsequent 
related initiativesxv, the NIH Human Mi-
crobiome Projectxvi, and the Genotype-
Tissue Expression initiativexvii.  And, the 
use of data-centric and open paradigms 
continues today as projects like All of 
Us  and the Adolescent Brain Cognitive 
Development Studyxix get underway. 
From Concept-Centric and Closed to 
Data-Centric and Open 
Despite many examples of data-cen-
tric and open approaches being used, 
most biomedical research is not con-
ducted that way.  For most research, the 
major public products are scientific pa-
pers reporting conclusions about the data, 
but the data themselves are almost never 
seen by others, much less shared with 
others.  Thus, the currency of most bio-
medical research is not the data, but ideas 
and concepts about the data; it is concept-
centric.  And, since data are not made 
available to others, most research re-
mains closed rather than open.  This, 
however, is about to change.  As society 
increasingly expects data from federally 
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funded research to be broadly accessible, 
as computational and communication 
technologies become ever more power-
ful, as the scientific opportunities af-
forded by open and data-centric para-
digms become more obvious, and as bi-
partisan policy directives from executive 
and legislative branches of the federal 
government encourage data sharing, it is 
likely that data-centric and open para-
digms will soon be used beyond the con-
fines of one-off initiatives.    
An important policy directive was is-
sued on February 22, 2013 by the Director 
of the White House Office of Science and 
Technology Policy (OSTP), Dr. John 
Holdren, wherein federal agencies with 
annual research and development budg-
ets exceeding $100 million were directed 
to increase public access to the results of 
the research they conduct or support, in-
cluding both the publications and the 
data underlying those publicationsxx.   
The National Institutes of Health is-
sued its plan for meeting the OSTP di-
rective in February 2015xxi.   Regarding 
access to research publications, the NIH 
already had a policy in place, and NLM 
had already developed PubMed Central 
as the infrastructure to provide public ac-
cess to them.  Starting in 2008, NIH re-
quired “scientists to submit final peer-re-
viewed journal manuscripts that arise 
from NIH funds to PubMed Central im-
mediately upon acceptance for publica-
tion”xxii.  Since the OSTP directive, several 
other agencies across the federal govern-
ment have opted to use PubMed Central 
as the infrastructure for publications sup-
ported by those agencies.  The NIH plan 
for making research data more accessible 
in response to the OSTP directive and in 
the interest of better science, is described 
below.  
What is NIH Doing to Make Digital 
Research Objects FAIR? 
As data and other DROs become 
more broadly accessible, it is important 
that NIH encourage and facilitate these 
objects being findable, accessible, in-
teroperable, and re-usable.  There are ex-
isting and ongoing efforts at NIH that do 
or could support the FAIR principles; 
some of these are described, below. 
Findable – PubMed is a powerful 
platform for discovery of the biomedical 
literature, with coverage from 1946 to the 
present, and more selectively before 1946. 
The full contents of some 5600 journals 
are indexed with a curated, hierarchically 
organized terminology (MeSHxxiii) that al-
lows for sophisticated search and re-
trieval of citations. This infrastructure 
could be leveraged to make other DROs, 
such as datasets, findable, perhaps by 
building on MeSH in ways that would be 
well suited to categorize and find da-
tasets, with a pointer to the locations of 
the datasets. 
  Some publication citations in Pub-
Med already link to datasetsxxiv.  And, it 
is expected that within the next year, in-
vestigators submitting papers to PubMed 
Central will be able to also deposit in 
PubMed Central the datasets associated 
with those papers.  Both mechanisms al-
low data to be findable via the literature. 
Data repositories make their constitu-
ent data findable and NLM supports a 
portal with information about, and links 
to, some 70 data repositories that are sup-
ported by NIHxxv, and that allow data 
egress and ingress.  This portal can be 
used to identify data repositories contain-
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ing data of interest, and the search mech-
anisms available for the respective repos-
itories can be used to find specific da-
tasets. 
Looking forward, NLM is now ex-
ploring specifications that could be used 
to describe datasets with appropriate 
metadata, ideally in ways that would be 
widely applicable across much of the di-
verse data landscape of biomedical re-
search.   
Accessible – As was mentioned, the 
2013 OSTP directive to increase public ac-
cess to research results supported with 
federal funding included increasing ac-
cess to both research publications and re-
search data.  Highlights of the NIH plan 
to make research data more accessible in-
clude that policies would apply to all 
NIH mechanisms of research support, in-
cluding grants, contracts, and intramural 
projects, and would apply at all levels of 
support, regardless of the amount of 
budget.   
Data management plans would be ex-
pected from all applications and pro-
posals for research support, and would 
provide information such as the type and 
amounts of data expected to be generated 
or collected, the data-related standards to 
be used, how data might be made availa-
ble to others, provisions for re-use, etc.  
The data management plans would be 
part of the review process, with the re-
view of the plan being able to affect the 
merit score.   
Peer review of the data management 
plans would allow plans to be reviewed 
on a project-by-project basis, with the ex-
pertise and norms of that particular re-
search community brought to bear on the 
assessment.  Peer review of data manage-
ment plans, with that review affecting the 
overall score of the review, will also raise 
the salience of the plans with applicants 
and reviewers, encouraging an appropri-
ate level of consideration being paid to 
them both parties.   
Interoperable – Data, and other 
DROs, are made interoperable with other 
DROs, tools and data resources through 
the use of standards.  The NLM develops, 
supports the development of, and stew-
ards widely-used standards, particularly 
for biomedical literature, healthcare in-
formation technology, and certain types 
of research data.  These standards in-
clude
xxvii
xxvi terminologies, such as the Uni-
fied Medical Language System  and 
SNOMED CT, coding systems like 
LOINCxxviii, and metadata tagging speci-
fications like JATSxxix.   
   Across NIH, data repositories and 
major research initiatives supported by 
NIH, its institutes and centers, also spec-
ify data-related standards.  Some of these, 
such as the Human Connectome Project, 
have incentivized investigators beyond 
that initiativexxx to adopt their data-re-
lated standards as their adoption allows 
investigators not supported by the initia-
tive to rigorously compare their data with 
the initiative’s data.  
As the value of the use of common 
standards becomes more evident, insti-
tutes and centers of the NIH are increas-
ingly communicating about and coordi-
nating such efforts.  For example, the 
NIH Clinical Common Data Elements 
Task Force maintains a conversation 
among all institutes and centers on this 
topic and is currently considering how to 
best harmonize related infrastructure, as 
well as developing and documenting  best 
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practices for standing up common data 
element initiatives.  The NLM has also 
developed web resources on behalf of 
the Task Force, including a portal to 
NIH collections of common data ele-
ments and related resources
xxxii. The repository allows 
users to search for specific common data 
elements, by topic, funding opportunity 
announcement, etc., as well as serving as 
a platform to compare and harmonize 
similar but distinct common data ele-
ments.  Such harmonization mitigates the 
unnecessary proliferation of these typ
xxxi, and a re-
pository for common data elements 
used in research conducted or sup-
ported by NIH
es 
of standards.   
NIH is now launching pilot projects 
to create cloud instances as virtual spaces 
for data, analytic tools, repositories, and 
other DROs. Digital research objects that 
populate this NIH Data Commons will 
need to be compliant FAIR principles and 
certain standardsxxxiii,  enhancing their in-
teroperability.  
Re-usable – Digital research objects 
are re-usable and most useful when they 
are linked to each other.  Such linkage de-
pends upon metadata of the DRO 
(metadata are data or information about 
DRO).  For example, if the DRO is a re-
search dataset, it might have both hu-
man-readable and machine-readable 
types of metadata.  The human-readable 
metadata might be a set of descriptors 
such as “confocal image, mouse, brain” to 
reflect the instrument source of the data, 
and the organism and tissue type from 
which the data were collected.  The ma-
chine-readable metadata might be a 
string of alpha numeric characters.  Ide-
ally, the identifier is unique so it resolves 
to the intended object, and persistent so 
that version of that object will not be lost 
over time, and its provenance tracked 
(i.e., changes to the object can be moni-
tored by relating the identifier to identifi-
ers of subsequent, modified, versions of 
it).  
Linkage of DROs forms the basis of a 
digital ecosystem because such linkage 
allows DROs to interact in an automated 
and dynamic way.   A simple example of 
such an ecosystem is shown below, 
where each disc represents a particular 
person, each square a particular dataset, 
and each triangle a particular scientific 
publication. And, each of these objects is 
associated with other specific objects 
through linkage of their respective per-
sistent unique identifiers, shown as lines 
connecting them.   
  In Example A, below, three individu-
als participated in activities resulting in a 
dataset (i.e., they are the data authors), 
and two of them were authors on the pa-
per.  In Example B, the same dataset pro-
duced by the same three data authors re-
sulted in a second publication by the 
same two paper authors.  In Example C, 
the dataset and data authors from 
examples A and B, as well as an addi-
tional dataset authored by a subset of 
data authors in previous example and a 
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new author, served as the basis of a scien-
tific publication for which all authors of 
both datasets served as paper authors.   
At this time, through some of NIH’s 
research data repositories, bibliographic 
data platform (i.e., PubMed), administra-
tive systems for grants, investigator’s 
identifiers, and other DRO identifiers, 
simple linkage like that illustrated here is 
possible for certain sets of DROs (e.g., as 
does the National Database for Autism 
Researchxxxiv).   
Now, imagine an ecosystem where all 
DROs have persistent unique identifiers 
and are associated with (linked to) all 
DROs appropriately.  So, in addition to 
identifiers of particular datasets, publica-
tions, investigators and their affiliations, 
also present and appropriately linked in 
this ecosystem are identifiers such as 
those for the specific instrument used to 
collect the data (e.g., the particular mag-
netic resonance imaging scanner), the 
specific data-related standards (e.g., 
NIfTI-1
xxxvi), pre
xxxvii, etc.  For any given 
DRO (whether a dataset, paper, data au-
thor, paper author, software tool, etc.), 
such an ecosystem would allow a person 
xxxviii xxxix
xxxv data format), the software 
used to statistically analyze the data (e.g., 
AFNI_17.2.05 -registered experi-
mental protocols
- or a computer - to be aware of all of the
other DROs directly linked to it.  Of,
course, this awareness of associations
need not be limited to the first degree of 
association, but higher levels; analysis of 
such higher dimensional relationships 
across networks of DROs could provide 
interesting insights about the nature of 
the science, itself.  Comprehensive 
awareness of associations in and by the 
ecosystem could be maintained by some-
thing like a blockchain approach , , 
with the DRO links representing the 
transactions tracked.  Such an approach 
could provide a way to characterize the 
DROs and maintain provenance at-scale 
in an open, distributed, and reliable man-
ner, adding significant value to the eco-
system of science and scholarship.  
Data Science and Open Science at 
NIH: Looking Forward 
With the retirement of Dr. Donald A. 
B. Lindberg as the Director of NLM, the
Director of NIH asked a working group
of the Advisory Committee to the Direc-
tor to examine the nexus of NLM’s pur-
view and expertise and the future of data
science and open science in biomedi-
cinexl.  Later that year, the working group
issued a reportxli with six recommenda-
tions, all of which were adopted by the
Director of NIH.  One of these was that
“NLM should be the intellectual and pro-
grammatic epicenter for data science at
NIH” and another that “NLM should
lead efforts to support and catalyze open
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science, data sharing, and research repro-
ducibility, striving to promote the con-
cept that biomedical information and its 
transparent analysis are public goods.” 
Soon thereafter, Dr. Patricia Flatley Bren-
nan accepted the position as Director of 
NLM.   
Since Dr. Brennan’s arrival at NLM, 
input has been solicited and received 
from many, including NLM leadership 
and staff, leadership of NIH institutes 
and centers, external experts, and the 
general public through meetings, work-
shops, committee deliberations, town 
halls, and published requests for infor-
mation (some of these activities have 
been undertaken as part of the decadal 
NLM strategic planning process).  In-
formed by these ideas from diverse per-
spectives, a view has emerged of the key 
issues that need to be addressed as NLM 
assumes the leadership role for data sci-
ence and open science at NIH.  
A clear and urgent priority for bio-
medical data science and open science is 
to engage with others across NIH to de-
velop solutions for sustainability.  As 
more large scale, large cohort studies, in-
itiatives, and research programs are 
launched, the valuable data they produce 
must be housed, curated, and dissemi-
nated.  Economies of scale and experience 
can be realized with a strategic enterprise 
approach, solving the same problem once 
rather than multiple times, converging on 
common standards, common architec-
tures, coordination of acquisition activi-
ties around compute, and developing 
best practices for implementing and 
maintaining data assets and related infra-
structure.  Of course, it is important that 
trans-NIH approaches are flexible 
enough to meet the needs of particular 
studies, initiatives, and programs.  
Another important contributor to 
sustainability is the use of evidence-
based value assessment (e.g., cost/benefit 
analyses).  Decisions such as those about: 
which data to keep, at what level particu-
lar datasets should be curated, how long 
specific datasets should be kept, which 
infrastructure should be invested in, 
which policies should be implemented 
and at what level of compliance, would 
all benefit by having an empirically-de-
rived base of evidence for support.  Such 
evidence could be used to develop crite-
ria and heuristics for guidance about fu-
ture investments in data, infrastructure, 
and policy. 
Other priorities include the: 1) Strate-
gic engagement beyond NIH, as data, sci-
ence, and scholarship do not respect bor-
ders of nations, economic sectors or disci-
plines.  2) Development of a data-savvy 
workforce, including not only data scien-
tists, per se, but data scientists cross-
trained in biomedicine, biomedical scien-
tist cross-trained in data science, both in-
tramurally and extramurally.  And, as 
data science and open science figure 
more prominently in NIH portfolios of 
extramurally-supported research, pro-
gram officers, scientific review officers, 
and scientific policy staff of NIH must be-
come more familiar with these areas.  3) 
Promotion of open science through 
changes in policies, engagement with the 
public around data and open science is-
sues, and the development of tools de-
signed specifically for use by public to fa-
cilitate their participation in research ac-
tivities.  4) Research and innovation in 
data science and open science, develop-
ing new analytic approaches and tools, 
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solutions to challenges of curation at-
scale, and exploration of various flavors 
of artificial intelligence to harness the dy-
namic and expanding ecosystem of sci-
ence and scholarship.   
Finally, it is important to note that the 
behaviors of individuals and the prac-
tices of research-related organizations in 
a closed, concept-centric paradigm of sci-
ence and scholarship are very different 
than those required for an open, data-
centric paradigm.  For example, in the 
former data are not shared, while the lat-
ter depends upon sharing data (and other 
DROs).  The flip from the former para-
digm to the latter will require changes in 
incentives to both people and organiza-
tions comprising the biomedical research 
enterprise (e.g., universities, funders, 
publishers, professional societies, regula-
tory agencies, etc.).  Ideally, these incen-
tives would be distributed across the en-
tire enterprise and would be strategically 
aligned with each other to be mutually 
and maximally reinforcing, and avoiding 
unintended consequences.  Due to wide 
variations in how poised various biomed-
ical research domains are for adopting a 
data-centric and open paradigm (e.g., ge-
nomics already is largely thus; not so for 
epidemiology), such strategic incentive 
structures would likely be best designed 
and developed domain-by-domain, ra-
ther than across all areas of biomedicine 
at once.   
In closing, the cumulative biomedical 
knowledgebase and breathtakingly pow-
erful scientific technologies available to-
day present significant opportunities to 
understand health and mitigate illness.  A 
digital ecosystem wrought of data sci-
ence and open science promises to multi-
ply these opportunities many-fold.  With 
the right incentives in place, this promise 
could be realized in the foreseeable fu-
ture.  
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